Cargando…
Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
We compared hepatic and serum lipid changes in hepatocellular carcinoma (HCC) patients to have a better understanding of the molecular pathogenesis of this disease and discovery novel lipid biomarkers. Hepatic and serum lipid profiling was conducted in paired liver and serum samples from 50 HCC pati...
Autores principales: | Lu, Yonghai, Chen, Juanjuan, Huang, Chong, Li, Ning, Zou, Li, Chia, Sin Eng, Chen, Shengsen, Yu, Kangkang, Ling, Qingxia, Cheng, Qi, Zhu, Mengqi, Zhang, Weidong, Chen, Mingquan, Ong, Choon Nam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797031/ https://www.ncbi.nlm.nih.gov/pubmed/29435160 http://dx.doi.org/10.18632/oncotarget.23494 |
Ejemplares similares
-
Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients
por: CHEN, SHENGSEN, et al.
Publicado: (2016) -
A Critical Role of Peptidylprolyl Isomerase A Pseudogene 22/microRNA-197-3p/Peptidylprolyl Isomerase A Axis in Hepatocellular Carcinoma
por: Gu, Yuwei, et al.
Publicado: (2021) -
Occupational Health Response to SARS
por: Koh, David, et al.
Publicado: (2005) -
Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis
por: Bao, Suxia, et al.
Publicado: (2017) -
Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)